Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death.

Somatostatin (SS) and SS analogs have been shown to exert an antiproliferative effect on several transplantable tumors in animals and to reduce the growth of pancreatic, pituitary, and mammary tumor cells in vitro. We evaluated the effects that the SS analog SMS 201-995 exerts on growth, cell-cycle parameters, and suicidal cell death (apoptosis) of human breast cancer cells (MCF-7) in vitro. SMS 201-995 significantly reduced the MCF-7 cell growth induced by serum, estradiol, insulin, and insulin-like growth Factor-I in both short term and long term experiments. The effect was maximal when 10 nM estradiol was used as mitogen in long term cultures. SMS 201-995 treatment produced a slight but transient accumulation of cells in the G2/M phase but did not cause any noteworthy reduction in the percentage of proliferating cells. There was, instead, a time-related increase in the number of cells with the flow-cytometric characteristics of apoptosis in the cultures treated with the SS analog, which correlated well with its growth-inhibiting activity. It would, therefore, seem that SMS 201-995 exerts its inhibitory effect on MCF-7 cell growth in vitro mainly by enhancing the rate of programmed (or suicidal) cell death in the culture.

[1]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[2]  P. Pelicci,et al.  Inhibitory effect of the somatostatin analog octreotide on rat pituitary tumor cell (GH3) proliferation in vitro , 1990, Journal of endocrinological investigation.

[3]  B. Lewin.  Driving the cell cycle: M phase kinase, its partners, and substrates , 1990, Cell.

[4]  C. Sorenson,et al.  Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. , 1990, Journal of the National Cancer Institute.

[5]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[6]  B. Szende,et al.  Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75. , 1990, Journal of the National Cancer Institute.

[7]  I. Black,et al.  Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts , 1990, Nature.

[8]  J. Mckenzie,et al.  Do thyroid growth-promoting immunoglobulins exist? , 1990, The Journal of clinical endocrinology and metabolism.

[9]  H. Folch,et al.  Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisone. , 1990, Cellular immunology.

[10]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[11]  L. Hartwell,et al.  Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.

[12]  J. Reubi,et al.  The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer , 1989, Cancer.

[13]  A. Schally,et al.  Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Szende,et al.  Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Pradayrol,et al.  Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. , 1989, Endocrinology.

[16]  A. Schally.  Oncological applications of somatostatin analogues. , 1988, Cancer research.

[17]  M. Blankenstein,et al.  Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen , 1988, Journal of cellular physiology.

[18]  J. Foekens,et al.  Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. , 1987, Cancer research.

[19]  J. Klijn,et al.  Somatostatin receptors in human endocrine tumors. , 1987, Cancer research.

[20]  J. Reubi,et al.  Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. , 1986, Endocrinology.

[21]  S. Lamberts,et al.  Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. , 1985, The New England journal of medicine.

[22]  A. Schally,et al.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Furlanetto,et al.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. , 1984, Cancer research.

[24]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[25]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[26]  J. Gray,et al.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[28]  P. Dean.  A SIMPLIFIED METHOD OF DNA DISTRIBUTION ANALYSIS , 1980, Cell and tissue kinetics.

[29]  Bayard,et al.  Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. , 1978, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  N. Kyprianou,et al.  Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration , 1989, The Prostate.

[31]  P. Lemieux,et al.  Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. , 1988, International journal of immunopharmacology.

[32]  B. Katzenellenbogen,et al.  Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. , 1984, Cancer research.

[33]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.